Sentieon
1 known investors
Sentieon develops CPU-accelerated bioinformatics secondary analysis software that processes genomics sequencing data (FASTQ to VCF/GVCF) as drop-in replacements for tools like BWA-MEM, GATK, and Mutect2. It serves research institutions, hospitals, and clinical labs working in precision medicine, supporting short and long reads across sequencing platforms on x86 and ARM servers.
AI & Machine LearningBiotechHealthtech
Investors · 1
Frequently asked questions
- What does Sentieon do?
- Sentieon develops CPU-accelerated bioinformatics secondary analysis software that processes genomics sequencing data (FASTQ to VCF/GVCF) as drop-in replacements for tools like BWA-MEM, GATK, and Mutect2. It serves research institutions, hospitals, and clinical labs working in precision medicine, supporting short and long reads across sequencing platforms on x86 and ARM servers.
- Who are Sentieon's investors?
- Sentieon's investors include GRC Sinogreen.